CRISPR Therapeutics AG (CRSP) Discounted Future Market Cap - Discounting Cash Flows
CRISPR Therapeutics AG
CRSP (NASDAQ)

Estimated Value

USD

Market Price USD

* Values are not guaranteed, please do your own
research before making investment decisions.

Discounted Future Market Cap

This model estimates the intrinsic value of a common share by projecting the Future Market Capitalization using the estimated PE Ratio and then discounting it to the Present using an Annual Required Rate of Return.

Interactive Assumptions

Results

Present Value 25,217 Bil. USD
Estimated net income -352,696,135,656 Bil. USD
Estimated market capitalization 3,785,241,048,823 Bil. USD
Market capitalization discounted to present 2,167,127,800,281 Bil. USD
Shares Outstanding 85.94 Mil.
Earnings Per Share (EPS) -4.52 USD
Market Price 48.51 USD
Price to Earnings (PE) Ratio -10.81

Historical and forecasted data

In Millions of USD

Edit Chart Values 2025 2026 2027 2028 2029

amounts of USD except for #

2024 LTM 2025 2026 2027 2028 2029
Revenue 35 36.98 336.4 89,341 23,729,032 6,302,430,933 1,673,925,655,701
Revenue Growth Rate -90.57% 5.67% 861.1% 26,460% 26,460% 26,460% 26,460%
Net Income -366.3 -385.7 -70,874 -18,824,198 -4,999,707,069 -1,327,922,197,500 -352,696,135,656,107

amounts of USD except for #

Average LTM 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue 154.2 36.98 35 371.2 0.436 913.1 0.543 289.6 3.12 41 5.16 0.247
Cost of Revenue 107.4 125.6 110.2 130.2 110.2 17.95 269.4 179.4 113.8 69.8 42.24 12.57
Gross Profit 46.81 -88.65 -75.25 241 -109.8 895.1 -268.9 110.2 -110.6 -28.8 -37.07 -12.33
Gross Margin -7,661% -239.7% -215% 64.91% -25,190% 98.03% -49,510% 38.06% -3,542% -70.26% -717.9% -4,990%
Operating Income -189.8 -474.4 -466.6 -222.5 -673.2 373.5 -354.4 46.74 -158.9 -64.65 -68.13 -25.73
Operating Margin -21,750% -1,283% -1,333% -59.95% -154,390% 40.91% -65,270% 16.14% -5,088% -157.7% -1,319% -10,420%
Net Income -158.4 -385.7 -366.3 -153.6 -650.2 377.7 -348.9 66.86 -165 -68.36 -23.2 -25.83
Net Margin -21,070% -1,043% -1,046% -41.38% -149,120% 41.36% -64,250% 23.09% -5,281% -166.7% -449.3% -10,460%

amounts of USD except for #

Average LTM 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue 154.2 36.98 35 371.2 0.436 913.1 0.543 289.6 3.12 41 5.16 0.247
Revenue Growth Rate 26,460% 5.67% -90.57% 85,040% -99.95% 168,050% -99.81% 9,170% -92.38% 693.9% 1,991%
Net Income -158.4 -385.7 -366.3 -153.6 -650.2 377.7 -348.9 66.86 -165 -68.36 -23.2 -25.83
Net Margin -21,070% -1,043% -1,046% -41.38% -149,120% 41.36% -64,250% 23.09% -5,281% -166.7% -449.3% -10,460%
Net Income Growth Rate -51.8% 5.3% 138.4% -76.37% -272.2% -208.3% -621.8% -140.5% 141.4% 194.6% -10.17% 279.8%
Stockholders Equity 1,210 1,829 1,932 1,883 1,875 2,399 1,664 939.4 392.2 187.8 232.8 -29.1
Equity Growth Rate -24.11% -5.33% 2.62% 0.391% -21.84% 44.18% 77.15% 139.5% 108.8% -19.33% -900.2% 308.8%
Return on Invested Capital (ROIC) -405.5% -26.46% -25.39% -13.1% -35.23% 21.75% -62.87% 70.48% -3,451% -388.5% -934.7% 384.5%
After-tax Operating Income -191.7 -479.3 -471.2 -226.8 -672.8 371.7 -355.3 46.43 -159.5 -66.35 -69.58 -25.74
Income Tax Rate -0.735% -1.04% -0.989% -1.92% 0.05% 0.493% -0.232% 0.666% -0.336% -2.63% -2.13% -0.027%
Invested Capital 879.2 1,811 1,856 1,731 1,910 1,709 565.1 65.88 4.62 17.08 7.44 -6.69
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us